Clinical significance of macrophage phenotypes in cardiovascular disease

Heather J Medbury1, Helen Williams1, John P Fletcher1

  • 1Vascular Biology Research Centre, Department of Surgery, University of Sydney, Westmead Hospital, Westmead, NSW Australia.

Insights

Macrophages play key roles in atherosclerosis. M1 types promote disease, while M2 types aid plaque stability through repair and anti-inflammatory actions, offering therapeutic potential.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Atherosclerosis Research

Background:

  • Macrophage subsets (M1 and M2) have distinct roles in atherosclerosis.
  • M1 macrophages are pro-atherogenic, contributing to disease progression.
  • M2 macrophages exhibit tissue repair and anti-inflammatory properties, potentially promoting plaque stability.

Purpose of the Study:

  • To review the involvement of macrophage subsets in atherosclerosis progression and regression.
  • To explore the therapeutic potential of modulating macrophage function for plaque stabilization.

Main Methods:

  • Literature review of macrophage subset functions in atherosclerosis.
  • Analysis of findings from in vitro and small animal models.
  • Discussion of clinical relevance and future research directions.

Main Results:

  • M1 macrophages are consistently linked to pro-atherogenic effects.
  • M2 macrophages demonstrate potential for promoting plaque stability and repair.
  • Current understanding largely stems from preclinical models.

Conclusions:

  • Targeting macrophage function represents a promising therapeutic strategy for atherosclerosis.
  • Further research is needed to elucidate macrophage subset roles in the clinical setting.
  • Identifying key pathways is crucial for developing effective plaque stabilization therapies.